Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,897 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Colorado retinopathy of prematurity model: a multi-institutional validation study.
Cao JH, Wagner BD, Cerda A, McCourt EA, Palestine A, Enzenauer RW, Braverman RS, Wong RK, Tsui I, Gore C, Robbins SL, Puente MA Jr, Kauffman L, Kong L, Morrison DG, Lynch AM. Cao JH, et al. Among authors: kong l. J AAPOS. 2016 Jun;20(3):220-5. doi: 10.1016/j.jaapos.2016.01.017. Epub 2016 May 7. J AAPOS. 2016. PMID: 27166790
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study.
Wallace DK, Kraker RT, Freedman SF, Crouch ER, Hutchinson AK, Bhatt AR, Rogers DL, Yang MB, Haider KM, VanderVeen DK, Siatkowski RM, Dean TW, Beck RW, Repka MX, Smith LE, Good WV, Hartnett ME, Kong L, Holmes JM; Pediatric Eye Disease Investigator Group (PEDIG). Wallace DK, et al. Among authors: kong l. JAMA Ophthalmol. 2017 Jun 1;135(6):654-656. doi: 10.1001/jamaophthalmol.2017.1055. JAMA Ophthalmol. 2017. PMID: 28448664 Free PMC article. Clinical Trial.
A Dosing Study of Bevacizumab for Retinopathy of Prematurity: Late Recurrences and Additional Treatments.
Wallace DK, Dean TW, Hartnett ME, Kong L, Smith LE, Hubbard GB, McGregor ML, Jordan CO, Mantagos IS, Bell EF, Kraker RT; Pediatric Eye Disease Investigator Group. Wallace DK, et al. Among authors: kong l. Ophthalmology. 2018 Dec;125(12):1961-1966. doi: 10.1016/j.ophtha.2018.05.001. Epub 2018 Jun 7. Ophthalmology. 2018. PMID: 29887334 Free PMC article. Clinical Trial.
Visual Outcomes and Complications After Lensectomy for Traumatic Cataract in Children.
Writing Committee for the Pediatric Eye Disease Investigator Group (PEDIG); Bothun ED, Repka MX, Dean TW, Gray ME, Lenhart PD, Li Z, Morrison DG, Wallace DK, Kraker RT, Cotter SA, Holmes JM. Writing Committee for the Pediatric Eye Disease Investigator Group (PEDIG), et al. JAMA Ophthalmol. 2021 Jun 1;139(6):647-653. doi: 10.1001/jamaophthalmol.2021.0980. JAMA Ophthalmol. 2021. PMID: 33956055 Free PMC article.
Visual Acuity and Ophthalmic Outcomes 5 Years After Cataract Surgery Among Children Younger Than 13 Years.
Repka MX, Dean TW, Kraker RT, Li Z, Yen KG, de Alba Campomanes AG, Young MP, Rahmani B, Haider KM, Whitehead GF, Lambert SR, Kurup SP, Kraus CL, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Repka MX, et al. JAMA Ophthalmol. 2022 Mar 1;140(3):269-276. doi: 10.1001/jamaophthalmol.2021.6176. JAMA Ophthalmol. 2022. PMID: 35142808 Free PMC article.
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes.
Freedman SF, Hercinovic A, Wallace DK, Kraker RT, Li Z, Bhatt AR, Boente CS, Crouch ER, Hubbard GB, Rogers DL, VanderVeen D, Yang MB, Cheung NL, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Freedman SF, et al. Ophthalmology. 2022 Oct;129(10):1120-1128. doi: 10.1016/j.ophtha.2022.05.019. Epub 2022 Jun 1. Ophthalmology. 2022. PMID: 35660415 Free PMC article.
7,897 results